Every version by contractor
Open a version for its full policy text, contracts, codes and related NCDs. Covered codes are the count of ICD-10-CM codes in the version's billing and coding article; a dash means the export attaches no coded article.
Which diagnoses each contractor covers
Across the 2 versions with a coded billing and coding article, 111 ICD-10-CM codes are covered by at least one contractor: 19 by every version and 92 (83%) by only some of them. L37616 (Noridian Healthcare Solutions, LLC) covers the most codes no other version lists (52). L37581 (Palmetto GBA) leaves out the most codes that every other version covers (52), the version where a diagnosis accepted elsewhere is most often absent. The comparison is mechanical: it counts codes on the lists and does not weigh the policy text, frequency limits or documentation rules, which can matter as much as the list.
Unique codes appear on that version's covered list only; missing codes are covered by every other version but not by this one. Lists are the union of the coded billing and coding articles linked to each LCD (MCD release 2026-11-12).
Where the lists part
Three-character ICD-10-CM categories ranked by how many of their codes are covered by some versions and not others; a category near the top is where checking the local list matters most.
| Category | Category title (FY2027) | Codes that differ |
|---|---|---|
| T45 | Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified | 15 |
| O12 | Gestational [pregnancy-induced] edema and proteinuria without hypertension | 12 |
| T36 | Poisoning by, adverse effect of and underdosing of systemic antibiotics | 12 |
| T52 | Toxic effect of organic solvents | 12 |
| Q61 | Cystic kidney disease | 11 |
| N06 | Isolated proteinuria with specified morphological lesion | 9 |
| R80 | Proteinuria | 6 |
| N17 | Acute kidney failure | 5 |
| R31 | Hematuria | 5 |
| N18 | Chronic kidney disease (CKD) | 3 |
| R79 | Other abnormal findings of blood chemistry | 1 |
| Z92 | Personal history of medical treatment | 1 |
Code-by-contractor sample
All 92 codes covered by some versions and not others, codes that most versions cover first and no more than three per category in the first pass. Y means the version's covered list includes the code.
| ICD-10-CM | Description (FY2027) | L37581 | L37616 |
|---|---|---|---|
| N06.0 | Isolated proteinuria with minor glomerular abnormality | — | Y |
| N06.3 | Isolated proteinuria with diffuse mesangial proliferative glomerulonephritis | — | Y |
| N06.4 | Isolated proteinuria with diffuse endocapillary proliferative glomerulonephritis | — | Y |
| N06.5 | Isolated proteinuria with diffuse mesangiocapillary glomerulonephritis | — | Y |
| N06.6 | Isolated proteinuria with dense deposit disease | — | Y |
| N06.7 | Isolated proteinuria with diffuse crescentic glomerulonephritis | — | Y |
| N06.8 | Isolated proteinuria with other morphologic lesion | — | Y |
| N06.9 | Isolated proteinuria with unspecified morphologic lesion | — | Y |
| N06.A | Isolated proteinuria with C3 glomerulonephritis | — | Y |
| N17.0 | Acute kidney failure with tubular necrosis | — | Y |
| N17.1 | Acute kidney failure with acute cortical necrosis | — | Y |
| N17.2 | Acute kidney failure with medullary necrosis | — | Y |
| N17.8 | Other acute kidney failure | — | Y |
| N17.9 | Acute kidney failure, unspecified | — | Y |
| N18.2 | Chronic kidney disease, stage 2 (mild) | — | Y |
| N18.4 | Chronic kidney disease, stage 4 (severe) | — | Y |
| N18.5 | Chronic kidney disease, stage 5 | — | Y |
| O12.10 | Gestational proteinuria, unspecified trimester | — | Y |
| O12.11 | Gestational proteinuria, first trimester | — | Y |
| O12.12 | Gestational proteinuria, second trimester | — | Y |
| O12.13 | Gestational proteinuria, third trimester | — | Y |
| O12.14 | Gestational proteinuria, complicating childbirth | — | Y |
| O12.15 | Gestational proteinuria, complicating the puerperium | — | Y |
| O12.20 | Gestational edema with proteinuria, unspecified trimester | — | Y |
| O12.21 | Gestational edema with proteinuria, first trimester | — | Y |
| O12.22 | Gestational edema with proteinuria, second trimester | — | Y |
| O12.23 | Gestational edema with proteinuria, third trimester | — | Y |
| O12.24 | Gestational edema with proteinuria, complicating childbirth | — | Y |
| O12.25 | Gestational edema with proteinuria, complicating the puerperium | — | Y |
| Q61.00 | Congenital renal cyst, unspecified | — | Y |
| Q61.01 | Congenital single renal cyst | — | Y |
| Q61.02 | Congenital multiple renal cysts | — | Y |
| Q61.11 | Cystic dilatation of collecting ducts | — | Y |
| Q61.19 | Other polycystic kidney, infantile type | — | Y |
| Q61.2 | Polycystic kidney, adult type | — | Y |
| Q61.3 | Polycystic kidney, unspecified | — | Y |
| Q61.4 | Renal dysplasia | — | Y |
| Q61.5 | Medullary cystic kidney | — | Y |
| Q61.8 | Other cystic kidney diseases | — | Y |
| Q61.9 | Cystic kidney disease, unspecified | — | Y |
| R31.0 | Gross hematuria | — | Y |
| R31.1 | Benign essential microscopic hematuria | — | Y |
| R31.21 | Asymptomatic microscopic hematuria | — | Y |
| R31.29 | Other microscopic hematuria | — | Y |
| R31.9 | Hematuria, unspecified | — | Y |
| R79.89 | Other specified abnormal findings of blood chemistry | — | Y |
| R80.0 | Isolated proteinuria | — | Y |
| R80.1 | Persistent proteinuria, unspecified | — | Y |
| R80.2 | Orthostatic proteinuria, unspecified | — | Y |
| R80.3 | Bence Jones proteinuria | — | Y |
| R80.8 | Other proteinuria | — | Y |
| R80.9 | Proteinuria, unspecified | — | Y |
| T36.AX1A | Poisoning by fluoroquinolone antibiotics, accidental (unintentional), initial encounter | Y | — |
| T36.AX1D | Poisoning by fluoroquinolone antibiotics, accidental (unintentional), subsequent encounter | Y | — |
| T36.AX1S | Poisoning by fluoroquinolone antibiotics, accidental (unintentional), sequela | Y | — |
| T36.AX2A | Poisoning by fluoroquinolone antibiotics, intentional self-harm, initial encounter | Y | — |
| T36.AX2D | Poisoning by fluoroquinolone antibiotics, intentional self-harm, subsequent encounter | Y | — |
| T36.AX2S | Poisoning by fluoroquinolone antibiotics, intentional self-harm, sequela | Y | — |
| T36.AX3A | Poisoning by fluoroquinolone antibiotics, assault, initial encounter | Y | — |
| T36.AX3D | Poisoning by fluoroquinolone antibiotics, assault, subsequent encounter | Y | — |
| T36.AX3S | Poisoning by fluoroquinolone antibiotics, assault, sequela | Y | — |
| T36.AX4A | Poisoning by fluoroquinolone antibiotics, undetermined, initial encounter | Y | — |
| T36.AX4D | Poisoning by fluoroquinolone antibiotics, undetermined, subsequent encounter | Y | — |
| T36.AX4S | Poisoning by fluoroquinolone antibiotics, undetermined, sequela | Y | — |
| T45.AX1A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), initial encounter | Y | — |
| T45.AX1D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter | Y | — |
| T45.AX1S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela | Y | — |
| T45.AX2A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter | Y | — |
| T45.AX2D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter | Y | — |
| T45.AX2S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela | Y | — |
| T45.AX3A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounter | Y | — |
| T45.AX3D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter | Y | — |
| T45.AX3S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela | Y | — |
| T45.AX4A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounter | Y | — |
| T45.AX4D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter | Y | — |
| T45.AX4S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequela | Y | — |
| T45.AX5A | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter | Y | — |
| T45.AX5D | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter | Y | — |
| T45.AX5S | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela | Y | — |
| T52.891A | Toxic effect of other organic solvents, accidental (unintentional), initial encounter | Y | — |
| T52.891D | Toxic effect of other organic solvents, accidental (unintentional), subsequent encounter | Y | — |
| T52.891S | Toxic effect of other organic solvents, accidental (unintentional), sequela | Y | — |
| T52.892A | Toxic effect of other organic solvents, intentional self-harm, initial encounter | Y | — |
| T52.892D | Toxic effect of other organic solvents, intentional self-harm, subsequent encounter | Y | — |
| T52.892S | Toxic effect of other organic solvents, intentional self-harm, sequela | Y | — |
| T52.893A | Toxic effect of other organic solvents, assault, initial encounter | Y | — |
| T52.893D | Toxic effect of other organic solvents, assault, subsequent encounter | Y | — |
| T52.893S | Toxic effect of other organic solvents, assault, sequela | Y | — |
| T52.894A | Toxic effect of other organic solvents, undetermined, initial encounter | Y | — |
| T52.894D | Toxic effect of other organic solvents, undetermined, subsequent encounter | Y | — |
| T52.894S | Toxic effect of other organic solvents, undetermined, sequela | Y | — |
| Z92.26 | Personal history of immune checkpoint inhibitor therapy | Y | — |
Download every covered code with a column per LCD (CSV). The LCD coverage variation report ranks every multi-contractor title by how far its lists diverge.
How to use the comparison
Start from the state where the service is furnished and open that contractor's version; its billing and coding article carries the diagnosis codes the claims system will test. For a group that bills in several jurisdictions, the version with the smallest covered list is the safe common denominator for pre-service review, and the version with the largest list shows what documentation can support an appeal elsewhere. The L37616 version is the one most searched for this title; the LCD lookup guide explains how jurisdictions are assigned, and the LCD hub lists every topic that more than one contractor has written.
For teams evaluating QuickIntell software
Where QuickIntell fits across jurisdictions
For teams working across MAC jurisdictions, evaluate how requirements, source policies and documentation review should be organized for each case. Confirm jurisdiction-specific scope and supported actions during a QuickAuth evaluation; compare claim and denial follow-up separately in QuickRCM.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions
Why are there 2 LCDs called "Lab: Cystatin C Measurement"?
Each Medicare Administrative Contractor writes its own Local Coverage Determination for its jurisdiction. 2 contractors publish a policy with this title covering 23 states; they often start from one contractor's text and then revise separately, so dates, criteria and diagnosis lists differ by jurisdiction.
Which "Lab: Cystatin C Measurement" LCD applies to my claim?
The one written by the contractor that processes the claim: the A/B MAC for the state where the service is furnished, or the DME MAC region for equipment. The table lists each policy's states; open the policy for that jurisdiction and its billing and coding article.
How different are the diagnosis lists?
Across the 2 versions with a coded billing and coding article, 111 ICD-10-CM codes are covered by at least one contractor: 19 by every version and 92 (83%) by only some of them. A diagnosis accepted under one contractor's version can deny under another's, so a group that bills in several jurisdictions checks the list of the contractor that processes each claim.
When were these policies last revised?
Revision effective dates run from 2025-03-13 to 2025-09-11. A claim is judged against the version in force on the date of service.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file lcd.csvSHA-256 2e0eda3351aa3d47…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
Policy metadata and code counts are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.